Author

N. Dezorella

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Assay:imaging· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1

Frequent Co-Authors

A. Abashidze· 1 shared A. Plotnikov· 1 shared B. Dassa· 1 shared B. Geiger· 1 shared B. Haim· 1 shared D. Gur· 1 shared E. Bigelman· 1 shared E. P. Papapetrou· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Abashidze

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Biogenic plate-like guanine crystals form via templated nucleation of thin crystal leaflets on amyloid scaffolds

Z. Eyal, R. Deis, N. Varsano, N. Dezorella, K. Rechav, L. Houben, D. Gur

The paper shows that biogenic plate-like guanine crystals form through templated nucleation on amyloid scaffolds in zebrafish larvae.

bioRxiv · Sep 29, 2022 · PreprintBiophysics

Kynurenic acid, a key L-tryptophan-derived metabolite, protects the heart from an ischemic damage

E. Bigelman, M. Pasmanik-Chor, B. Dassa, M. Itkin, S. Malitsky, O. Dorot, E. Pichinuk, S. Levin-Zaidman, N. Dezorella, A. Abashidze, Y. Kleinberg, G. Keren, M. Entin Meer

This paper identifies kynurenic acid as a protective metabolite that enhances cardiac cell viability and mitochondrial function following ischemic damage.

bioRxiv · May 17, 2022Cell Biology

Rock inhibitors target SRSF2 leukemia by disrupting cell mitosis and nuclear morphology

M. Su, T. Fleisher, I. Grosheva, M. B. Horev, M. Olszewska, B. Haim, A. Plotnikov, S. Carvalho, Y. Moskovitz, M. Minden, N. Chapal-Ilani, E. P. Papapetrou, N. Dezorella, T. Cheng, N. Kaushansky, , L. I. Shlush

This study identifies ROCK inhibitors as effective targeting agents for SRSF2 mutant leukemia by disrupting mitosis and nuclear morphology in vitro and in xenograft models.

bioRxiv · Feb 15, 2022 · PreprintCancer Biology